pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for Delirium

NCT01785290 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1800

Enrollment

OTHER

Sponsor class

Conditions

Delirium

Interventions

DRUG: Haloperidol 1 mg/q8h
DRUG: Haloperidol 2 mg/q8h
DRUG: Placebo

Sponsor

Radboud University Medical Center

Collaborators

[object Object]